For Personalized Prevention And Treatment Strategies

Hereditary Cancer Tests

Mapping the human genome has made it possible to quickly and economically refine a patient’s cancer risk through an analysis of inherited mutations. Our inherited cancer test panel is one of the industry’s largest.

Screening for hereditary cancers gives patients—especially those with a family history of cancer—relevant information about their cancer risk, and helps providers make more informed decisions and develop an appropriate preventative or treatment plan.

  • Bone Cancers
  • Skin Cancers
  • Breast & Gynecologic
  • Endocrine
  • Head & Neck
  • Nervous system
  • Soft tissue
  • Colorectal
  • Hematopoietic
  • GI Tract

Carrier Screening

Our carrier screening allows providers to determine if prospective parents carry a genetic mutation that could cause a serious inherited disorder in their baby, such as cystic fibrosis, sickle cell and Tay-Sachs disease.

Newborn Genetics Tests

Newborn genetic screening identifies genetic disorders in infants. Early intervention to treat these disorders can help eliminate or reduce symptoms that might otherwise cause a lifetime of disability.

  • Polypharmacy
  • Cardiac
  • Gastroenterology
  • Pain
  • Psychotropic
  • Surgery

Pharmacogenetics Tests

Studies have shown that incorporating genetic factors into the prescribing process can help improve efficacy, reduce adverse effects and help avoid drug-drug interactions.

Our pharmacogenetic tests help healthcare providers target treatment and medications to a patient’s genetics by analyzing the genes that produce the specific drug targets, or enzymes that metabolize a medication or are associated with immune response.